In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

Suspended

• Conditions: Infections, Bacterial
• Interventions: Drug: In Vitro activity of Tigecycline among key bacterial pathogens exhibiting multidrug resistance

• Registration Number: NCT01132417
• Lead Sponsor: King Faisal University

Brief Summary

Observational: studies in human beings in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.

Detailed Description

Study Phase Definition: Phase of investigation, as defined by the US FDA for trials involving investigational new drugs. Select only one.

N/A: for trials without phases Observational Study Design Case-control: group of individuals with specific characteristics (e.g., conditions or exposures) compared to group(s) with different Time Perspective Cross-sectional: observations or measurements made at a single point in time, usually at subject enrollment Biospecimen Retention - select one Samples Without DNA - samples retained, with no potential for DNA extraction from any retained samples (e.g., fixed tissue, plasma) Biospecimen Description

Sputum, whole blood, urine, tissue Enrollment

Single group study Number of Groups/Cohorts Definition: Number of study groups/cohorts. Enter 1 for a single-group study. Many observational studies have one group/cohort; case control studies typically have two.

One study group, anticipated samples in the rang of 400-500 samples 8. Arms, Groups and Interventions N/L Group/Cohort Label

Study Timeline

• Study Start: 2009-09
• Study First Submitted: 2009-09-19
• Study First Submitted QC: 2010-05-27
• Study First Posted: 2010-05-28
• Status Verified: 2011-06
• Last Update Submitted: 2011-06-21
• Last Update Posted: 2011-06-23
• Primary Completion: 2012-06
• Study Completion: 2012-07

Recruitment & Eligibility

• Status: SUSPENDED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• All patients with infection with MDRs infections will be included

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Multidrug resistant (MDR)bacterial strains	In Vitro activity of Tigecycline among key bacterial pathogens exhibiting multidrug resistance	-

Trial Locations

Locations (1)

King Faisal Univrsity, Departmentof Microbiology and Immunology,, dammam branh; 🇸🇦 Dammam, Eastern, Saudi Arabia